Bliss GVS Pharma fixes book closure from July 9 for final dividend

1 min read     Updated on 23 Jun 2026, 08:29 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Bliss GVS Pharma Limited has fixed July 8, 2026, as the record date for a ₹1.00 per share final dividend, subject to shareholder approval at the 41st AGM on July 15, 2026. The share transfer books will remain closed from July 9 to July 15, 2026. The company also detailed e-voting schedules and TDS regulations for the dividend payout.

powered bylight_fuzz_icon
43770886

*this image is generated using AI for illustrative purposes only.

Bliss GVS Pharma Limited has fixed Wednesday, July 08, 2026, as the record date to determine shareholder entitlement for the final dividend for the financial year ended March 31, 2026. The Register of Members and Share Transfer Books will remain closed from Thursday, July 09, 2026, to Wednesday, July 15, 2026, for the 41st Annual General Meeting and dividend payment. The Board of Directors has recommended a final dividend of ₹1.00 per equity share, subject to approval at the meeting. If approved, payment will be made on or before Friday, August 14, 2026.

The 41st Annual General Meeting is scheduled to be held on Wednesday, July 15, 2026, at 11:00 AM through Video Conferencing or Other Audio-Visual Means. The agenda includes the adoption of financial statements for FY2025-26, the declaration of the final dividend, and the re-appointment of Mr. Narsimha Shibroor Kamath as Managing Director & CEO.

E-Voting and Participation Details

The company has provided remote e-voting facilities for shareholders. The remote e-voting period commences at 9:00 AM on Sunday, July 12, 2026, and concludes at 5:00 PM on Tuesday, July 14, 2026. Shareholders eligible to vote as on the cut-off date of Wednesday, July 08, 2026, may cast their votes electronically during this period or via e-voting during the meeting. The facility for remote e-voting is available to at least 1,000 members on a first-come, first-served basis, excluding large shareholders and promoters.

Tax Deduction on Dividend

The company stated that tax will be deducted at source (TDS) on the dividend payment. For resident shareholders, TDS will be deducted at 10% if PAN is registered, or 20% if not. No tax will be deducted if the total dividend does not exceed ₹5,000. Non-resident shareholders and other entities must submit relevant documents, such as Tax Residency Certificates, to avail of lower treaty rates. Shareholders must submit necessary declarations like Form 15G or 15H by Wednesday, July 08, 2026, to avoid higher deduction.

Historical Stock Returns for Bliss GVS Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-0.68%+6.94%+56.50%+167.45%+216.45%+328.88%

What factors might influence shareholder approval of the final dividend and the re-appointment of the Managing Director & CEO?

How could the TDS regulations impact dividend attractiveness for retail versus institutional investors?

What strategic initiatives is Bliss GVS Pharma likely to prioritize in FY2026-27 following the AGM?

Bliss GVS Pharma fixes record date for FY26 dividend

2 min read     Updated on 20 Jun 2026, 09:49 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Bliss GVS Pharma Limited has fixed July 08, 2026, as the record date for a final dividend of ₹1.00 per share, subject to approval at the 41st AGM on July 15, 2026. The meeting will be held via video conferencing, and the company detailed TDS norms, including 10% for residents with PAN and 20% for non-residents.

powered bylight_fuzz_icon
43408599

*this image is generated using AI for illustrative purposes only.

Bliss GVS Pharma Limited has fixed Wednesday, July 08, 2026, as the record date to determine shareholder eligibility for the final dividend of ₹1.00 per equity share for the financial year ended March 31, 2026. The dividend, recommended by the Board of Directors on May 12, 2026, is subject to shareholder approval at the 41st Annual General Meeting (AGM) scheduled for Wednesday, July 15, 2026, at 11:00 a.m. IST via video conferencing. The company has submitted the newspaper publication for the AGM to the National Stock Exchange of India and BSE Limited.

The AGM will be conducted through Video Conferencing (VC) or Other Audio Visual Means (OAVM) in compliance with the Ministry of Corporate Affairs and SEBI circulars. Shareholders attending via VC/OVAM will be counted for quorum purposes under Section 103 of the Companies Act, 2013. Electronic copies of the Notice of AGM and the Annual Report for FY26 will be sent to registered email addresses and made available on the company's website and stock exchange portals.

The company outlined the tax deduction at source (TDS) norms applicable to the dividend. For resident shareholders with a valid Permanent Account Number (PAN), TDS will be deducted at 10%. If the PAN is invalid, not linked with Aadhaar, or unavailable, the deduction rate increases to 20% under Section 397(2) of the Income Tax Act, 2025. Resident individuals are exempt from TDS if their total dividend income does not exceed ₹10,000 or if they submit valid declarations such as Form 121 or exemption certificates.

For non-resident shareholders, the domestic tax law mandates a withholding tax rate of 20%, plus applicable surcharge and cess. Shareholders may opt for beneficial rates under the Double Tax Avoidance Agreement (DTAA) by submitting a Tax Residency Certificate (TRC), digital Form 41, and a self-declaration of treaty eligibility. The company clarified that it is not obligated to apply DTAA rates if documents are incomplete or unsatisfactory.

Shareholders must update their bank account details and KYC information to facilitate timely dividend payments. The final dividend will be paid electronically to those with updated bank details. Any documents received after the record date will be accepted at the company's sole discretion, and tax deducted at a higher rate due to missing information can be claimed as a refund while filing income tax returns.

Key Dividend and AGM Details

Event Details
AGM Date July 15, 2026
Final Dividend ₹1.00 per equity share
Financial Year FY26
Record Date July 08, 2026
TDS Rate (Resident with PAN) 10%
TDS Rate (Invalid/No PAN) 20%
TDS Rate (Non-Resident) 20% + surcharge + cess

Historical Stock Returns for Bliss GVS Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-0.68%+6.94%+56.50%+167.45%+216.45%+328.88%

How will the approval of the final dividend at the AGM impact Bliss GVS Pharma's cash flow and capital allocation strategy for FY27?

What is the expected shareholder turnout for the virtual AGM, and could it influence the approval of the dividend or other resolutions?

Will the company maintain this dividend payout ratio in the future, or are there plans to adjust it based on FY27 performance?

More News on Bliss GVS Pharma

1 Year Returns:+216.45%